Given that EDA has been used clinically to treat ischemic stroke, the advancing knowledge we have provided here on the cardiac preconditioning effect of EDA via HIF-1α/HO-1 activation in sepsis may support a novel use of EDA as a treatment for septic patients. The gene discussed is HMOX1; the disease is Sepsis.